Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.55M | 15.86M | 22.60M | 22.68M | 20.38M |
| Total Depreciation and Amortization | 4.02M | 2.78M | 1.12M | 1.17M | 1.23M |
| Total Amortization of Deferred Charges | 61.00K | 22.00K | -- | -- | -- |
| Total Other Non-Cash Items | -5.03M | -186.00K | -3.48M | -3.84M | -2.34M |
| Change in Net Operating Assets | 8.95M | -5.39M | -3.20M | -6.24M | -3.28M |
| Cash from Operations | 19.55M | 13.08M | 17.05M | 13.77M | 16.00M |
| Capital Expenditure | -80.04M | -80.18M | -161.00K | -150.00K | -144.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -80.04M | -80.18M | -161.00K | -150.00K | -144.00K |
| Total Debt Issued | 40.00M | 40.00M | -- | -- | -- |
| Total Debt Repaid | -233.00K | -199.00K | -122.00K | -114.00K | -111.00K |
| Issuance of Common Stock | 152.00K | 333.00K | 457.00K | 466.00K | 426.00K |
| Repurchase of Common Stock | -176.00K | -5.28M | -5.41M | -5.66M | -5.56M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -447.00K | -398.00K | -- | -- | -- |
| Cash from Financing | 39.30M | 34.46M | -5.07M | -5.31M | -5.24M |
| Foreign Exchange rate Adjustments | -786.00K | 82.00K | -166.00K | 247.00K | 378.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.99M | -32.56M | 11.65M | 8.55M | 10.99M |